Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTt Electronics Regulatory News (TTG)

Share Price Information for Tt Electronics (TTG)

Share Price is delayed by 15 minutes
Get Live Data
115.60    0.00 (0.00%)
Bid:
115.60
Ask:
116.00
Spread: 0.40 (0.346%)
Market Cap: £206.21m
TTG Live PriceLast checked at - London Stock Exchange

Intraday Tt Electronics Share Chart

Acquisition

4 Jun 2018 07:00

RNS Number : 1135Q
TT Electronics PLC
04 June 2018
 

 

 

4 June 2018

 

TT Electronics plc

 

Acquisition of Precision Inc.

 

 

This announcement contains inside information

 

TT Electronics ("TT" or the "Group"), a global provider of engineered electronics for performance critical applications, today announces the acquisition of Precision Inc. ("Precision") for an initial consideration of $23.5 million and up to an additional $4.0 million which may become payable subject to business performance.

 

Headquartered in Minneapolis, US, Precision is an industry leading designer and manufacturer of precision electromagnetic product solutions for critical applications. Precision has customers in medical, industrial and aerospace and defence markets, served by around 160 employees in the US and China.

 

Precision brings new design, simulation and manufacturing capabilities to TT in electromagnetics, one of our focus areas for growth. Precision's products are primarily sold into medical applications including pace makers, neurological implants and other in-body equipment as well as external diagnostic equipment such as dialysis machines and MRI scanners. Precision also serves industrial and aerospace and defence customers in applications including satellite power supplies and aerospace guidance systems. Precision's capabilities include high-reliability, ultra-fine wire winding, particularly suited to components that require exceptionally high levels of precision. Precision will be integrated into the Power Electronics division.

 

In the year ended 31 December 2017, Precision reported revenues of $21.0 million and EBIT of $2.3 million. Gross assets were approximately $7.8 million as at 31 December 2017. The acquisition is expected to be immediately earnings enhancing, to generate mid-teens operating margins, and to exceed our 12% return on invested capital acquisition hurdle rate in the first full financial year of ownership.

 

Commenting on the acquisition, Richard Tyson, Chief Executive Officer said:

 

"The acquisition of Precision is the second acquisition since we transformed the Group with the sale of the Transportation division in 2017. The acquisition of Precision is an excellent fit with both our business and our strategy for growth and higher margins. It has a strong position in markets where the proliferation of electronics is increasingly important and will extend our capability for power electronic solutions in the important medical, industrial and aerospace and defence markets in the US. We remain committed to creating value for our shareholders and we expect to hit our financial return hurdle rate in the first full year.

 

I am delighted to welcome Precision's employees to TT as we continue to build differentiated capabilities and engineer smarter solutions together with our customers."

 

For further information please contact:

 

TT Electronics plc

Tel: +44 (0)1932 825 300

Richard Tyson, Chief Executive Officer

Mark Hoad, Chief Financial Officer

Emma Darke, Head of Investor Relations and Communications

 

 

MHP

Tel: +44 (0)20 3128 8100

Tim Rowntree / Katie Hunt

 

 

About TT Electronics

TT Electronics is a global provider of engineered electronics for performance critical applications. The Company works with market-leading customers in the industrial, aerospace and defence, medical, and transportation sectors. TT has three divisions, Sensors and Specialist Components, Power Electronics and Global Manufacturing Solutions.

The product offerings in the Sensors and Specialist Components division include circuit protection, current sensing, signal conditioning, optoelectronics, and sensors for torque, position, pressure, flow and temperature. The Power Electronics division typically designs and manufactures specialist, high reliability electronic components and sub-assemblies supplying into power management, engine controls and connectivity systems. The Global Manufacturing Solutions division provide high mix low volume manufacturing solutions for products in a wide range of end applications ranging from medical devices, to power control modules used in rail transport infrastructure.

Cautionary statement

This announcement contains forward-looking statements. These have been made by the directors in good faith based on the information available to them up to the time of their approval of this announcement. The directors can give no assurance that these expectations will prove to have been correct. Due to the inherent uncertainties, including both economic and business risk factors underlying such forward looking information, actual results may differ materially from those expressed or implied by these forward-looking statements. The directors undertake no obligation to update any forward-looking statements whether as a result of new information, future events or otherwise.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQEAPKDELSPEFF
Date   Source Headline
28th Apr 20226:05 pmRNSDirector/PDMR Shareholding
27th Apr 20225:20 pmRNSDirector/PDMR Shareholding
27th Apr 202211:22 amRNSHolding(s) in Company
6th Apr 20224:15 pmRNSAnnual Financial Report
17th Mar 20227:00 amRNSDirector/PDMR Shareholding
16th Mar 20224:16 pmRNSDirector/PDMR Shareholding
15th Mar 202211:29 amRNSDirector Declaration
14th Mar 20223:00 pmRNSDirector/PDMR Shareholding
14th Mar 20223:00 pmRNSDirector/PDMR Shareholding
9th Mar 20227:00 amRNSFull Year Results
1st Mar 20223:35 pmRNSTotal Voting Rights
2nd Feb 20224:30 pmRNSHolding(s) in Company
1st Feb 20223:05 pmRNSTotal Voting Rights
10th Jan 20227:00 amRNSAcquisition of Ferranti Power & Control business
4th Jan 20222:20 pmRNSTotal Voting Rights
22nd Dec 202110:07 amRNSHolding(s) in Company
15th Dec 20214:00 pmRNSHolding(s) in Company
1st Dec 20213:06 pmRNSTotal Voting Rights
23rd Nov 20217:00 amRNSTrading Update
1st Nov 20215:05 pmRNSBlock Listing Six Monthly Return
1st Nov 20214:56 pmRNSDirector/PDMR Shareholding
30th Sep 20219:40 amRNSDirector/PDMR Shareholding
1st Sep 20211:30 pmRNSTotal Voting Rights
5th Aug 20217:00 amRNSHalf-year Results
2nd Aug 20213:38 pmRNSTotal Voting Rights
2nd Jul 20215:10 pmRNSTotal Voting Rights
16th Jun 20211:32 pmRNSUpdate on 2021 LTIP Award Targets
14th Jun 202110:16 amRNSHolding(s) in Company
1st Jun 20218:11 amRNSTotal Voting Rights
13th May 20211:19 pmRNSResult of AGM
13th May 20217:00 amRNSAGM Trading Update
12th May 20214:39 pmRNSDirector/PDMR Shareholding
4th May 20213:00 pmRNSBlock listing Interim Review
4th May 202110:42 amRNSTotal Voting Rights
1st Apr 20214:22 pmRNSTotal Voting Rights
1st Apr 202111:23 amRNSAnnual Report and AGM Arrangements
29th Mar 20218:05 amRNSHolding(s) in Company
26th Mar 20217:00 amRNSVirolens® registration received in Great Britain
25th Mar 202112:11 pmRNSUpdate on Virolens
19th Mar 202112:11 pmRNSDirector/PDMR Shareholding
18th Mar 20213:18 pmRNSHolding(s) in Company
16th Mar 20213:50 pmRNSDirector/PDMR Shareholding
16th Mar 20213:49 pmRNSDirector/PDMR Shareholding
10th Mar 202112:40 pmRNSHolding(s) in Company
10th Mar 20217:00 amRNSFull Year Results
1st Mar 202112:30 pmRNSTotal Voting Rights
8th Feb 20216:20 pmRNSHolding(s) in Company
1st Feb 202111:36 amRNSTotal Voting Rights
20th Jan 20214:55 pmRNSHolding(s) in Company
19th Jan 20213:45 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.